BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16164734)

  • 21. Treatment of chronic leg ulcers with topical activated protein C.
    Whitmont K; Reid I; Tritton S; March L; Xue M; Lee M; Fulcher G; Sambrook P; Slobedman E; Cooper A; Jackson C
    Arch Dermatol; 2008 Nov; 144(11):1479-83. PubMed ID: 19015423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
    Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
    Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrent superior vena cava syndrome caused by IgD multiple myeloma.
    Farnault L; Chebrek S; Souteyrand P; Sebahoun G; Costello R
    Ann Hematol; 2012 Dec; 91(12):1977-8. PubMed ID: 22638757
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple myeloma and systemic amyloidosis.
    López L; González K; Navarrete G; Novales J; Guarneros A; Cortés B; Téllez G
    Int J Dermatol; 2008 Feb; 47(2):165-7. PubMed ID: 18211489
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurological aspects of multiple myeloma].
    Golenkov AK; Guseva LL; Zlatkina AR; Lagutina TS; Markova VI
    Ter Arkh; 1986; 58(9):47-9. PubMed ID: 3787490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West].
    Holdrinet RS
    Ned Tijdschr Geneeskd; 1998 Oct; 142(43):2373-4. PubMed ID: 9864516
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fever of unknown origin as the clinical manifestation of multiple myeloma activity].
    Giraldo MP; Cuesta I; Bergua J; Pinilla J
    Sangre (Barc); 1992 Oct; 37(5):415-6. PubMed ID: 1293789
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of multiple myeloma and arterial thrombosis.
    Raven W; Berghout A; van Houten A; Leebeek FW
    Ann Hematol; 2010 Apr; 89(4):419-20. PubMed ID: 19688212
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ulcero-necrotic purpura revealing Kahler's disease, with macroglobulinemia].
    Bureau Y; Barrière H; Senelar R; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):495-8. PubMed ID: 4967360
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple myeloma.
    Bhattacharya SK; Singh NK; Srivastava PK; Tripathi K; Somani PN
    J Indian Med Assoc; 1984 Nov; 82(11):394-7. PubMed ID: 6535796
    [No Abstract]   [Full Text] [Related]  

  • 31. Kappa light chain myeloma with initial cutaneous involvement.
    Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
    Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pinch grafting in treatment of leg ulcers].
    Majamaa H; Mustakari A
    Duodecim; 2004; 120(18):2203-8. PubMed ID: 15560452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Multiple myeloma -- case report].
    Zettl F; Jung W; Schroers R
    Dtsch Med Wochenschr; 2005 Feb; 130(6):277; quiz 287-90. PubMed ID: 15692901
    [No Abstract]   [Full Text] [Related]  

  • 34. [Severe cardiac insufficiency caused by myelomatosis not recognized previously].
    Schmidt EB; Sørensen E; Johansen P
    Ugeskr Laeger; 1985 Jul; 147(28):2233-4. PubMed ID: 4060283
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D; Rajkumar SV; Nowakowski GS; Gertz MA; Dispenzieri A; Lacy MQ; Hayman S; Fonseca R; Lust JA; Kyle RA; Greipp PR; Witzig TE
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Multiple myeloma: description of a series of 170 cases].
    Bladé J; Rozman C; Montserrat E; Grañena A; Brugués R; Cervantes F; Feliu E; Marín P; Nomdedeu B; Vives-Corrons JL
    Med Clin (Barc); 1984 Feb; 82(7):287-94. PubMed ID: 6717133
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple eruptive dermatofibromas and immunosuppression: report of two cases and review of the literature.
    Zaccaria E; Rebora A; Rongioletti F
    Int J Dermatol; 2008 Jul; 47(7):723-7. PubMed ID: 18613883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multiple myeloma. Clinical review of 56 cases].
    López Alvarez J; Sanz Marca A; Aboin Massieu FJ
    Rev Clin Esp; 1983 Nov; 171(3):175-8. PubMed ID: 6669751
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results, failures and perspectives in therapy of multiple myeloma].
    Bessmel'tsev SS; Abdulkadyrov KM
    Vopr Onkol; 2002; 48(2):146-52. PubMed ID: 12227061
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment with VAD of a myelodysplastic syndrome occurring during the course of a smoldering multiple myeloma.
    Cortesão E; Espadana A; Laranjeiro P; Jara M; Orfão A
    Leuk Res; 2009 Jan; 33(1):195-7. PubMed ID: 18511113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.